United States HR 5381: International Pharmaceutical Transparency Act of 2019

Status: Referred to the Subcommittee on Health. (as of 2019-12-11)

State: United States · Session: 116 · Bill: HR 5381

Subjects: Consumer affairs, Drug safety, medical device, and laboratory regulation, Prescription drugs

Sponsors: Scott DesJarlais

View United States HR 5381 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.